NPLS — NP Life Sciences Health Industry Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro Cap

Annual income statement for NP Life Sciences Health Industry, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.043	0.015	0.035	0.102	0.165
Selling / General / Administrative Expenses
Total Operating Expenses	0.152	0.146	0.101	0.121	0.165
Operating Profit	-0.109	-0.131	-0.066	-0.019	-0.001
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.109	-0.131	-0.066	-0.019	-0.001
Provision for Income Taxes
Net Income After Taxes	-0.109	-0.131	-0.066	-0.019	-0.003
Net Income Before Extraordinary Items
Net Income	-0.109	-0.131	-0.066	-0.019	-0.003
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-0.109	-0.131	-0.066	-0.019	-0.003
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.003	-0.003	-0.002	-0	-0
Dividends per Share